Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Correction

---
identifier: "/us/fr/2015-03688"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2015-03688"
section_name: "Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Correction"
positive_law: false
currency: "2015-02-24"
last_updated: "2015-02-24"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2015-03688"
document_type: "notice"
publication_date: "2015-02-24"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "80 FR 9733"
fr_volume: 80
docket_ids:
  - "Docket No. FDA-2015-N-0001"
fr_action: "Notice; correction."
---


#  Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration is correcting a notice entitled “Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting” that appeared in the *Federal Register* of February 6, 2015 (80 FR 6731). The document announced a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The document was published with the incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Lisa Granger, Office of Policy, Planning, Legislation, and Analysis, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993, 301-796-9115.

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of February 6, 2015, in FR Doc. 2015-02408, on page 6731, the following correction is made:

On page 6731, in the first column, in the Docket No. heading, “[Docket No. FDA-2011-N-0824]” is corrected to read “[Docket No. FDA-2015-N-0001]”.

Dated: February 17, 2015.

Leslie Kux,

Associate Commissioner for Policy.